Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Checking for atrial fibrillation with a smartphone camera pulse reading

Compares a smartphone camera pulse check with ECG in people evaluated for atrial fibrillation.

Plain-language title generated from the registry record
Registry title: Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

Key facts

Where
Zwolle, NetherlandsSee the site

Where in Netherlands

  • Isala ZwolleZwolle, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Happitech BV
Trial code
NCT07779213
Record updated
21 August 2026
Original description
The protocol is designed to enroll patients from at least 3 diverse clinical sites with smartphones who are being evaluated for the presence or absence of atrial fibrillation (AF) using the Heart Rhythm Software algorithm running on their smartphones. Algorithm output will be compared to a gold standard of 12-lead ECG recorded with a simultaneous PPG measurement.Read full original descriptionShow less

Detection of Atrial Fibrillation Using Photoplethysmography From Smartphone Cameras

The protocol is designed to enroll patients from at least 3 diverse clinical sites with smartphones who are being evaluated for the presence or absence of atrial fibrillation (AF) using the Heart Rhythm Software algorithm running on their smartphones. Algorithm output will be compared to a gold standard of 12-lead ECG recorded with a simultaneous PPG measurement.

Inclusion: Adults aged 22 years or older; Owns a smartphone and knows how to operate and navigate different applications; Individuals able to read, understand, and sign the consent form; Cardiology patients consulting the cardiac outpatient clinic; History of persistent AF or other cardiac rhythm.

Exclusion: Patients with implantable neurostimulators, cardiac implantable device in an atrial or ventricular paced rhythm documented on a 12-lead ECG during the initial study visit; Participants with cognitive impairments; Individuals who cannot read, speak, and/or understand English.

ClinicalTrials.gov NCT07779213